Skip to main content
Back
Watch Compare

Humacyte, Inc.

Data quality: 100%
HUMAW
Nasdaq Manufacturing Chemicals
$0.09
▼ $0.02 (-17.74%)
Mkt Cap: 14.30 M
Price
$0.09
Mkt Cap
14.30 M
Day Range
$0.09 — $0.11
52-Week Range
$0.09 — $0.11
Volume
13,868
Open $0.23
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -105.93 M
Capital intensive — 43.38% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-93.04%
Net Margin-2003.58%
Op. Margin-5306.04%

Safety

Debt / Equity
N/A
Current Ratio1.62
Interest Coverage-9.61

Valuation

PE (TTM)
-0.35
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.4 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -2003.6 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.04 M Net Income (TTM) -40.83 M
ROE N/A ROA -35.46%
Gross Margin N/A Operating Margin -5306.04%
Net Margin -2003.58% Free Cash Flow (TTM) -105.93 M
ROIC -93.04% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.62
Interest Coverage -9.61 Asset Turnover 0.02
Working Capital 15.77 M Tangible Book Value -4.75 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.35 Forward P/E N/A
P/B Ratio N/A P/S Ratio 7.02
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -740.86%
Market Cap 14.30 M Enterprise Value -5.19 M
Per Share
EPS (Diluted TTM) -0.26 Revenue / Share 0.01
FCF / Share -0.67 OCF / Share -0.66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 43.38% FCF Conversion 259.41%
SBC-Adj. FCF -114.76 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 2.04 M — — — —
Net Income -40.83 M -148.70 M -110.78 M -11.97 M -233,333.0
EPS (Diluted) -0.26 -1.26 -1.07 -0.12 —
Gross Profit — — — — —
Operating Income -108.14 M -114.40 M -100.05 M -84.58 M -249,524.0
EBITDA — — — — —
R&D Expenses 69.30 M 88.60 M 76.55 M 63.26 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 11.25 M 9.28 M 6.60 M 6.20 M —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 116.37 M 137.87 M 128.22 M 204.30 M 101.26 M
Total Liabilities 113.26 M 190.54 M 114.68 M 87.37 M 2.10 M
Shareholders' Equity 3.11 M -52.67 M 13.55 M 116.93 M 5.00 M
Total Debt 35.44 M — — — —
Cash & Equivalents 50.50 M 44.94 M 80.45 M 149.77 M 1.09 M
Current Assets 67.80 M 47.86 M 83.28 M 154.21 M 1.24 M
Current Liabilities 18.37 M 19.95 M 18.44 M 19.58 M 247,945.0